The Evolution of Sequence of Treatment and Axillary Management in Early-stage Breast Cancer

Moderator(s)

• 

  Laura Dominici, MD

  Associate Chief of Surgery
  Brigham and Women's Faulkner Hospital; Associate Surgeon, Brigham and Women's Hospital, Dana-Farber Cancer Institute
  Scituate, Massachusetts, United States

  Disclosure(s): No financial relationships to disclose
• 

  Astrid Botty van den Bruele, MD

  Assistant Professor of Surgery
  Duke University Medical Center, North Carolina, United States

  Disclosure(s): No financial relationships to disclose

Presentations:

• 9:35am – 9:45am ET

  Early-stage (T1cN0) Triple Negative or HER2 Positive Breast Cancer: Upfront Surgery or Preoperative Systemic Therapy?
  

  Presenter: Judy C. Boughey, MD (she/her/hers) – Mayo Clinic
• 9:45am – 9:55am ET

  Early-stage ER Positive HER2 Negative Breast Cancer: Upfront Surgery or Preoperative Systemic Therapy?
  

  Presenter: Lee G. Wilke, MD (she/her/hers) – University of Wisconsin, School of Medicine and Public Health, Madison, WI
• 9:55am – 10:10am ET

  Early-stage ER Positive HER2 Negative Node Positive Breast Cancer: Is there a Role for Sentinel Lymph Node Surgery with Localization in Upfront Surgery Setting or After Preoperative Endocrine Therapy?
  

  Presenter: Anita Mamtani, MD (she/her/hers) – Memorial Sloan Kettering Cancer Center
• 10:10am – 10:20am ET

  Early-stage Breast Cancer with Negative Axillary Ultrasound: Can we Omit Axillary Surgery?
  

  Presenter: Carlos A. Garcia-Etienne, MD, FSSO (he/him/his) – Casa di Cura Sant'Anna – Privatklinik, Merano, Bolzano
• 10:20am – 10:30am ET

  Questions & Discussion